Nearly a year after Brazil's Superior Court of Justice (STJ) ordered the government to regulate the cultivation of cannabis for medical and pharmaceutical purposes , the process remains stalled. The National Health Surveillance Agency (ANVISA) has once again requested additional time, admitting that it was unable to finalize the regulatory framework within the deadlines imposed by the court.
At the 16th public meeting of the agency's collegiate council, held on October 8, 2025, Director-Rapporteur Thiago Campos presented an update on the work underway. He emphasized that ANVISA is coordinating its efforts with the Attorney General's Office (AGU) and several ministries, including those of Health and Agriculture, to develop " technical, safe, and legally sound " regulations.
However, Mr. Campos acknowledged that the process has proven to be much more complex than expected, particularly on sensitive issues such as the THC limit for cultivated plants.
"We must avoid a regulatory cap on THC that would make research and medications already authorized by ANVISA with higher levels unviable. The debate must be based on scientific evidence and not on moral perceptions," he said.
Read more at NewsWeed
